Page-4 of CSIR

CSIR-IICB: COVID-19 may affect respiratory centre of brain

A team of scientists from CSIR – Indian Institute of Chemical Biology (IICB), Kolkata has undertaken a study on the neuro-invasive potential of COVID-19 and said that the virus may infect the respiratory centre of the brain. The researchers have ..

Month: 

Clinical trial begins of plant based drug for Covid-19

On 5th June, 2020, the Drugs Controller General of India allowed Sun Pharmaceutical to conduct trial for the first phytopharmaceutical or plant based drug AQCH to treat covid-19 patients. The trial has begun by Sun pharmaceutical in collaboration with ICGEB ..

Atal Innovation Mission: To promote Entrepreneurship

On June 5, 2020, the Council of Scientific and Industrial Research (CSIR) and Atal Innovation Mission came together to promote culture of innovation and entrepreneurship in areas of mutual interest. Highlights The CSIR incubators will work under Atal Innovative Mission ..

Month: 

India finds a tool to get deeper insight into Parkinson’s Disease

The Scientists of IIT Dhanbad and CSIR (Council of Scientific and Industrial Research) have teamed up together to find a major cause of Parkinson’s disease a solution. Key Findings Parkinson’s disease is a neurodegenerative disease and so far, no cure ..

Month: 

CSIR and AYUSH Ministry begin clinical trials of four Ayurvedic Drugs

On May 13, 2020, the Council of Scientific and Industrial Research and the Ministry of AYUSH began clinical trials of four Ayurvedic drugs. The four formulations include Ashwagandha, Guduchi + Pippali, Yashtimadhu and AYUSH-64. Highlights A Taskforce has been formed ..

Month: 

NMITLI Programme of CSIR to conduct “hmAbs” trial to neutrialize COVID-19

The Council of Scientific and Industrial Research (CSIR) under its New Millennium Indian Technology Leadership Initiative (NMITLI) is to develop human monoclonal antibodies (hmAbs). These antibodies will neutralise COVID-19 virus in patients. Highlights The CSIR on one side is fighting ..

Month: